- Home
- PZZA vs OCS Comparison
PZZA vs OCS Comparison
Compare PZZA & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PZZA
- OCS
- Stock Information
- Founded
- PZZA 1984
- OCS 2003
- Country
- PZZA United States
- OCS Switzerland
- Employees
- PZZA N/A
- OCS N/A
- Industry
- PZZA Restaurants
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- PZZA Consumer Discretionary
- OCS Health Care
- Exchange
- PZZA Nasdaq
- OCS Nasdaq
- Market Cap
- PZZA 1.1B
- OCS 1.0B
- IPO Year
- PZZA 1993
- OCS N/A
- Fundamental
- Price
- PZZA $49.88
- OCS $19.16
- Analyst Decision
- PZZA Buy
- OCS Strong Buy
- Analyst Count
- PZZA 12
- OCS 3
- Target Price
- PZZA $51.36
- OCS $35.33
- AVG Volume (30 Days)
- PZZA 1.4M
- OCS 28.0K
- Earning Date
- PZZA 08-07-2025
- OCS 08-26-2025
- Dividend Yield
- PZZA 3.66%
- OCS N/A
- EPS Growth
- PZZA 4.47
- OCS N/A
- EPS
- PZZA 2.37
- OCS N/A
- Revenue
- PZZA $2,063,780,000.00
- OCS $847,333.00
- Revenue This Year
- PZZA $4.30
- OCS $18.70
- Revenue Next Year
- PZZA $3.68
- OCS $1,059.78
- P/E Ratio
- PZZA $21.22
- OCS N/A
- Revenue Growth
- PZZA N/A
- OCS N/A
- 52 Week Low
- PZZA $30.16
- OCS $10.79
- 52 Week High
- PZZA $60.75
- OCS $23.08
- Technical
- Relative Strength Index (RSI)
- PZZA 63.04
- OCS 48.93
- Support Level
- PZZA $47.41
- OCS $18.98
- Resistance Level
- PZZA $49.50
- OCS $19.75
- Average True Range (ATR)
- PZZA 1.79
- OCS 0.43
- MACD
- PZZA -0.39
- OCS -0.10
- Stochastic Oscillator
- PZZA 53.35
- OCS 44.78
About PZZA Papa John's International Inc.
Papa John's is one of the largest players in the global QSR, or quick-service restaurant, pizza market, boasting more than 6,000 restaurants across nearly 50 countries at the end of 2024. The firm operates a predominantly franchised system, owning 9% of its restaurants and generating revenue from franchise royalties, sales of pizza and related products at its company-owned stores, and sales from its commissary supply chain. The firm is the fourth-largest limited-service pizza chain globally and third in the US (Euromonitor International), with a sizable presence in the UK, China, South Korea, and Chile.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.